Skip to main content

Advertisement

SpringerLink
Log in

Role of NADPH cytochrome P450 reductase in activation of RH1

  • Original Article
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

RH1 is a new bioreductive agent that is an excellent substrate for the two-electron reducing enzyme, NAD(P)H quinone oxidoreductase 1 (NQO1). RH1 may be an effective NQO1-directed antitumor agent for treatment of cancer cells having elevated NQO1 activity. As some studies have indicated that RH1 may also be a substrate for the one-electron reducing enzyme, NADPH cytochrome P450 reductase (P450 Red), P450 Red may contribute to the activation of RH1 where NQO1 activities are low and P450 Red activities are high. The mean P450 Red activity in the human tumor cell line panel used by NCI for evaluation of new anticancer agents is 14.8 nmol min−1 mg prot−1, while the mean NQO1 activity in these cell lines is 199.5 nmol min−1 mg prot−1. Thus, we investigated whether P450 Red could play a role in activating RH1.

Methods

Reduction of RH1 by purified human P450 Red was investigated using electron paramagnetic resonance and spectroscopic assays. The ability of RH1 to produce DNA damage following reduction by P450 Red was studied using gel assays. To determine the role of P450 Red in activation of RH1 in cells, cell growth inhibition studies with inhibitors of P450 Red and NQO1 were carried out in T47D human breast cancer cells and T47D cells transfected with the human P450 Red gene (T47D-P450) that have P450 Red activities of 11.5 and 311.8 nmol min−1 mg prot−1, respectively.

Results

Reduction studies using purified P450 Red and NQO1 confirmed that RH1 can be reduced by both enzymes, but redox cycling was slower following reduction by NQO1. RH1 produced DNA strand breaks and crosslinks in isolated DNA after reduction by either P450 Red or NQO1. DPIC, an inhibitor of P450 Red, had no effect on cell growth inhibition by RH1 in T47D cells, and had only a small effect on cell growth inhibition by RH1 in the presence of the NQO1 inhibitor, dicoumarol, in T47D-P450 cells.

Conclusions

These results demonstrated that P450 Red does not contribute to the activation of RH1 in cells with normal P450 Red activity and plays only a minor role in activating this agent in cells with high levels of this enzyme. These studies confirmed that P450 Red could activate RH1 and provided the first direct evidence that RH1 could produce both DNA strand breaks and DNA crosslinks after reduction by P450 Red. However, the results strongly suggest that P450 Red does not play a significant role in activating RH1 in cells with normal P450 Red activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

RH1:

2,5-Diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone

P450 Red:

NADPH cytochrome P450 reductase

NQO1:

NAD(P)H quinone oxidoreductase 1

T47D-P450:

T47D cells transfected with the human NADPH cytochrome P450 reductase gene

EPR:

Electron paramagnetic resonance

DPIC:

Diphenyliodonium chloride

IC50 :

Concentration of drug that reduced the relative absorbance fraction to 0.5

References

  1. Barnabé N, Zastre J, Venkataram S, Hasinoff BB (2002) Deferiprone protects against doxorubicin-induced myocyte cytotoxicity. Free Radic Biol Med 33:266–275

    Article  PubMed  Google Scholar 

  2. Begleiter A, Robotham E, Leith MK (1992) Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia. Mol Pharmacol 41:677–682

    PubMed  CAS  Google Scholar 

  3. Benson AM, Hunkeler MJ, Talalay P (1980) Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc Natl Acad Sci USA 77:5216–5220

    Article  PubMed  CAS  Google Scholar 

  4. Berardini MD, Souhami RL, Lee CS, Gibson NW, Butler J, Hartley JA (1993) Two structurally related diaziridinylbenzoquinones preferentially cross-link DNA at different sites upon reduction with DT-diaphorase. Biochemistry 32:3306–3312

    Article  PubMed  CAS  Google Scholar 

  5. Bolton JL, Trush MA, Penning TM, Dryhurst G, Monks TJ (2000) Role of quinones in toxicology. Chem Res Toxicol 13:135–160

    Article  PubMed  CAS  Google Scholar 

  6. Cenas N, Anusevicius Z, Nivinskas H, Miseviciene L, Sarlauskas J (2004) Structure-activity relationships in two-electron reduction of quinones. Meth Enzymol 382:258–277

    PubMed  CAS  Google Scholar 

  7. Cummings J, Ritchie A, Butler J, Ward TH, Langdon S (2003) Activity profile of the novel aziridinylbenzoquinones MeDZQ and RH1 in human tumor xenografts. Anticancer Res 23:3979–3984

    PubMed  CAS  Google Scholar 

  8. Digby T, Leith MK, Thliveris JA, Begleiter A (2005) Effect of NQO1 induction on the antitumor activity of RH1 in human tumors in vitro and in vivo. Cancer Chemother Pharmacol 56:307–316

    Article  PubMed  CAS  Google Scholar 

  9. Fitzsimmons SA, Workman P, Grever M, Paull K, Camalier R, Lewis AD (1996) Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9. J Natl Cancer Inst 88:259–269

    Article  PubMed  Google Scholar 

  10. Fourie J, Guziec Jr F, Guziec L, Monterrosa C, Fiterman DJ, Begleiter A (2004) Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanism of cytotoxicity. Cancer Chemother Pharmacol 53:191–203

    Article  PubMed  CAS  Google Scholar 

  11. Halliwell B, Gutteridge JMC (1999) Free radicals in biology and medicine. Clarendon, Oxford

    Google Scholar 

  12. Hasinoff BB, Wu X, Begleiter A, Guziec L, Guziec F, Giorgianni A, Yang S, Jiang Y, Yalowich JC (2006) Structure-activity study of the interaction of bioreductive benzoquinone alkylating agents with DNA topoisomerase II. Cancer Chemother Pharmacol 57:221–233

    Article  PubMed  CAS  Google Scholar 

  13. Hoban PR, Walton MI, Robson CN, Godden J, Stratford IJ, Workman P, Harris AL, Hickson ID (1990) Decreased NADPH:cytochrome P−450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditions. Cancer Res 50:4692–4697

    PubMed  CAS  Google Scholar 

  14. Johnston JB, Verburg L, Shore T, Williams M, Israels LG, Begleiter A (1994) Combination therapy with nucleoside analogs and alkylating agents. Leukemia 8(suppl):S140–S143

    PubMed  Google Scholar 

  15. Kim JY, West CM, Valentine H, Ward TH, Patterson AV, Stratford IJ, Roberts SA, Hendry JH (2004) Cytotoxicity of the bioreductive agent RH1 and its lack of interaction with radiation. Radiother Oncol 70:311–317

    Article  PubMed  CAS  Google Scholar 

  16. Loadman PM, Phillips RM, Lim LE, Bibby MC (2000) Pharmacological properties of a new aziridinylbenzoquinone, RH1 (2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone), in mice. Biochem Pharmacol 59:831–837

    Article  PubMed  CAS  Google Scholar 

  17. Malkinson AM, Siegel D, Forrest GL, Gazdar AF, Oie HK, Chan DC, Bunn PA, Mabry M, Dykes DJ, Harrison SD Jr, Ross D (1992) Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin C. Cancer Res 52:4752–4757

    PubMed  CAS  Google Scholar 

  18. Marshall RS, Paterson MC, Rauth AM (1989) Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions. Br J Cancer 59:341–346

    PubMed  CAS  Google Scholar 

  19. Monks TJ, Jones DC (2002) The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinone-thioethers. Curr Drug Metab 3:425–438

    Article  PubMed  CAS  Google Scholar 

  20. Nemeikaite-Ceniene A, Sarlauskas J, Anusevicius Z, Nivinskas H, Cenas N (2003) Cytotoxicity of RH1 and related aziridinylbenzoquinones: involvement of activation by NAD(P)H:quinone oxidoreductase (NQO1) and oxidative stress. Arch Biochem Biophys 416:110–118

    Article  PubMed  CAS  Google Scholar 

  21. O’Brien PJ (1991) Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact 80:1–41

    Article  PubMed  CAS  Google Scholar 

  22. Ollinger K, Brunmark A (1991) Effect of hydroxy substituent position on 1,4-naphthoquinone toxicity to rat hepatocytes. J Biol Chem 266:21496–21503

    PubMed  CAS  Google Scholar 

  23. Pan SS, Andrews PA, Blover CJ, Bachur NR (1984) Reductive activation of mitomycin C and mitomycin C metabolite catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase. J Biol Chem 259:959–966

    PubMed  CAS  Google Scholar 

  24. Patterson AV, Saunders MP, Chinje EC, Talbot DC, Harris AL, Stratford IJ (1997) Overexpression of human NADPH:cytochrome c (P450) reductase confers enhanced sensitivity to both tirapazamine (SR 4233) and RSU 1069. Br J Cancer 76:1338–1347

    PubMed  CAS  Google Scholar 

  25. Phillips AH, Langdon RG (1962) Hepatic triphosphopyradine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies. J Biol Chem 237:2652–2660

    PubMed  CAS  Google Scholar 

  26. Powis G (1989) Free radical formation by antitumor quinones. Free Radic Biol Med 6:63–101

    Article  PubMed  CAS  Google Scholar 

  27. Riley RJ, Workman P (1992) DT-diaphorase and cancer chemotherapy. Biochem Pharmacol 43:1657–1669

    Article  PubMed  CAS  Google Scholar 

  28. Rockwell S, Sartorelli AC, Tomasz M, Kennedy KA (1993) Cellular pharmacology of quinone bioreductive alkylating agents. Cancer Metastasis Rev 12:165–176

    Article  PubMed  CAS  Google Scholar 

  29. Ross D, Siegel D, Beall H, Prakash AS, Mulcahy RT, Gibson NW (1993) DT-diaphorase in activation and detoxification of quinones. Cancer Metastasis Rev 12:83–101

    Article  PubMed  CAS  Google Scholar 

  30. Seng F, Ley K (1972) Simple synthesis of 3-amino-1,2,4-benzotriazine 1,4-dioxide. Angew Chem Int Ed Eng 11:1009–1010

    Google Scholar 

  31. Sharp SY, Kelland LR, Valenti MR, Brunton LA, Hobbs S, Workman P (2000) Establishment of an isogenic human colon tumor model for NQO1 gene expression: application to investigate the role of DT-diaphorase in bioreductive drug activation in vitro and in vivo. Mol Pharmacol 58:1146–1155

    PubMed  CAS  Google Scholar 

  32. Siegel D, Gibson NW, Preusch PC, Ross D (1990) Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res 50:7483–7489

    PubMed  CAS  Google Scholar 

  33. Strobel HW, Dignam JD (1978) Purification and properties of NADPH-cytochrome P-450 reductase. Meth Enzymol 52:89–96

    Article  PubMed  CAS  Google Scholar 

  34. Sun X, Ross D (1996) Quinone-induced apoptosis in human colon adenocarcinoma cells via DT-diaphorase mediated bioactivation. Chem-Biol Interac 100:267–276

    Article  CAS  Google Scholar 

  35. Swallow AJ (1982) Physical chemistry of semiquinones. In: Trumpower BL (ed) Function of quinones in energy conserving systems. Academic, New York pp 59–72

    Google Scholar 

  36. Tudor G, Alley M, Nelson CM, Ruili, Covell DG, Gutierrez P, Sausville EA (2005) Cytotoxicity of RH1: NAD(P)H:quinone acceptor oxidoreductase (NQO1)-independent oxidative stress and apoptosis induction. Anti-Cancer Drugs 16:381–391

    Article  PubMed  CAS  Google Scholar 

  37. Winski SL, Hargreaves RHJ, Butler J, Ross D (1998) A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: Identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent. Clin Cancer Res 4:3083–3088

    PubMed  CAS  Google Scholar 

  38. Winski SL, Swann E, Hargreaves RHJ, Dehn DL, Butler J, Moody CJ, Ross D (2001) Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones. Biochem Pharmacol 61:1509–1516

    Article  PubMed  CAS  Google Scholar 

  39. Zhu BZ, Zhao HT, Kalyanaraman B, Frei B (2002) Metal-independent production of hydroxyl radicals by halogenated quinones and hydrogen peroxide: an ESR spin trapping study. Free Radic Biol Med 32:465–473

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Manitoba Institute of Cell Biology, CancerCare Manitoba, Department of Internal Medicine, University of Manitoba, 675 McDermot Avenue, R3E 0V9, Winnipeg, MB, Canada

    Asher Begleiter & Marsha K. Leith

  2. Manitoba Institute of Cell Biology, CancerCare Manitoba, Department of Pharmacology & Therapeutics, University of Manitoba, 675 McDermot Avenue, R3E 0V9, Winnipeg, MB, Canada

    Asher Begleiter

  3. Faculty of Pharmacy, University of Manitoba, R3T 2N2, Winnipeg, MB, Canada

    Daywin Patel & Brian B. Hasinoff

Authors
  1. Asher Begleiter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marsha K. Leith
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daywin Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Brian B. Hasinoff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Asher Begleiter.

Additional information

Supported by grants from the National Cancer Institute of Canada with funds from the Canadian Cancer Society and the CancerCare Manitoba Foundation to A.B., by grants from the Canadian Institutes of Health Research to B.B.H. and by a Canada Research Chair in Drug Development to B.B.H.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Begleiter, A., Leith, M.K., Patel, D. et al. Role of NADPH cytochrome P450 reductase in activation of RH1. Cancer Chemother Pharmacol 60, 713–723 (2007). https://doi.org/10.1007/s00280-007-0417-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-007-0417-8

Keywords

Search

Navigation